NLS Pharmaceutics AG (NLSPW) — Free Cash Flow Generation Index
Latest as of June 2019:
1.00x
NLS Pharmaceutics AG (NLSPW) has a Free Cash Flow Generation Index of 1.00x as of June 2019. Free cash flow of $712.96K represents 1% of operating cash flow ($712.96K). Check NLSPW goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
FCF Generation Index
1.00x
Free Cash Flow / Operating CF
Free Cash Flow
$712.96K
USD
Operating Cash Flow
$712.96K
USD
Capital Expenditures
$0.00
USD
Annual Free Cash Flow Generation for NLS Pharmaceutics AG (None–None)
Year-by-year Free Cash Flow Generation Index for NLS Pharmaceutics AG. Check NLS Pharmaceutics AG (NLSPW) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).